By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Blueprint Medicines 



Cambridge  Massachusetts  02140  U.S.A.
Phone: 617-585-2033 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 9/19/2014 10:31:29 AM
First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 9/19/2014 8:02:57 AM
Blueprint Medicines Discovers Novel Cancer Drug Targets 9/10/2014 9:56:28 AM
Blueprint Medicines To Participate In Morgan Stanley (MST) Global Healthcare Conference 2014 9/9/2014 8:50:15 AM
Blueprint Medicines Presents Positive Data On BLU-554 For Hepatocellular Carcinoma 9/8/2014 9:10:23 AM
Blueprint Medicines To Present At Wedbush 2014 Life Sciences Management Access Conference 8/6/2014 8:48:59 AM
Blueprint Medicines Appoints Jeffrey Albers As Chief Executive Officer 7/24/2014 8:13:41 AM
Blueprint Medicines To Present At JMP Securities Healthcare Conference 6/20/2014 8:20:47 AM
Blueprint Medicines Presents Positive Data On First Selective FGFR4 Inhibitor 4/7/2014 9:22:08 AM
Blueprint Medicines To Present On The First Isoform Selective FGFR4 Inhibitor At The American Association for Cancer Research Annual Meeting 2014 3/25/2014 9:12:37 AM
12
//-->